Stay updated on Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    No significant changes were detected between the two screenshots of the study page. The core study details—title, conditions, interventions, eligibility criteria, and outcome measures—remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:24:28.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Updated page with a government-funding status notice and an OS/operating details section, plus a version bump to v3.2.0; previous v3.1.0 reference removed.
    Difference
    4%
    Check dated 2025-10-05T10:21:07.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T03:16:49.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' link was removed; no substantive changes to pricing, stock, or other core content.
    Difference
    0.2%
    Check dated 2025-09-13T17:43:16.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T15:26:29.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as various types of proteins and antibodies, while removing several specific medical terms and references to previous versions.
    Difference
    3%
    Check dated 2025-08-30T12:12:44.000Z thumbnail image

Stay in the know with updates to Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.